RFID Tests Are Positive For CVS And Pharmaceuticals - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


RFID Tests Are Positive For CVS And Pharmaceuticals

The retailer, along with eight others, wraps up the first phase of an industrywide RFID test.

CVS Corp. continues to test radio-frequency identification technology both in its internal operations and with a group of drug suppliers, distributors, and retailers--initiatives that the national drugstore chain says are paying off with promising results.

The retailer is one of nine participating in a pilot designed to establish an RFID operating and adoption model for the drug industry. The pilot is part of Project Jumpstart, an industry effort to fight counterfeit drugs and theft, which is a $30 billion problem for the pharmaceutical industry. Jumpstart's goal is to compare RFID tagging, which augments an end-to-end supply-chain model, to the current state-required "paper pedigrees," or paper credentials, that accompany drug shipments to ensure their authenticity.

The first phase of the pilot ended this month and included some RFID tagging at the item level. It also used track-and-trace technology from RFID chipmaker Matrics Inc. and supply-chain-software vendor Manhattan Associates Inc. Accenture, a global consulting, technology services, and outsourcing company, has also been actively involved in the project.

"During the pilot, scenarios were executed to validate the benefits of RFID against the business issues of pharmaceutical companies like CVS," says Jack DeAlmo, VP of inventory management and merchandise operations at CVS. DeAlmo spoke about CVS's RFID efforts Wednesday at this week's EPC Global U.S. Conference in Baltimore.

A second phase of the project will further explore RFID's value within the pharmaceutical supply chain. New companies such as Merck, Novartis, Sanofi-Synthelabo, Walgreen's, and Wyeth have joined and will participate in the next phase.

In addition to Project Jumpstart, CVS conducted an internal RFID pilot designed to speed up delivery of prescription drugs to customers and to improve the tracking of those drugs. "Every customer is our best customer, but our pharmacy customers are our most loyal," DeAlmo said. "We need to make sure that we deliver their prescriptions to them in the most efficient manner."

DeAlmo said the company learned several lessons from the industry pilot and CVS's internal pilot: optimum tag location is important, case tags are subject to handling conditions, quality assurance requires that both the RFID tags and any paper-based information are readable and compatible, and readers with more antenna power perform better. But DeAlmo warned that these lessons don't necessarily reflect RFID's effectiveness. "We have to be patient about seeing operational efficiencies with RFID, and it's going to take a few years before we see them."

Also at the EPC Global show, Accenture revealed findings from tests conducted during Project Jumpstart. Based on shipping, tracking, and tracing of nearly 13,500 packages during an eight-week period, results showed that EPC and RFID can help companies meet regulatory and retailer requirements, increase product security and consumer safety, improve order accuracy, and increase the speed of recalls and returns. Results were shared with the U.S. Food and Drug Administration.

Meanwhile, Manhattan Associates came out of the industry pilot's first phase with a new RFID offering for the pharmaceutical industry. The vendor this week released the EPC Manager, an addition to its Integration Platform for RFID. Greg Gilbert, Manhattan Associates' director of RFID solutions and strategy, says EPC Manager, which works with legacy systems and has capabilities to capture unique EPC data, is designed to test the business value of RFID among pharmaceutical manufacturers, distributors, and retailers.

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Comment  | 
Print  | 
More Insights
2020 State of DevOps Report
2020 State of DevOps Report
Download this report today to learn more about the key tools and technologies being utilized, and how organizations deal with the cultural and process changes that DevOps brings. The report also examines the barriers organizations face, as well as the rewards from DevOps including faster application delivery, higher quality products, and quicker recovery from errors in production.
10 Trends Accelerating Edge Computing
Cynthia Harvey, Freelance Journalist, InformationWeek,  10/8/2020
Is Cloud Migration a Path to Carbon Footprint Reduction?
Joao-Pierre S. Ruth, Senior Writer,  10/5/2020
IT Spending, Priorities, Projects: What's Ahead in 2021
Jessica Davis, Senior Editor, Enterprise Apps,  10/2/2020
Register for InformationWeek Newsletters
Current Issue
[Special Report] Edge Computing: An IT Platform for the New Enterprise
Edge computing is poised to make a major splash within the next generation of corporate IT architectures. Here's what you need to know!
White Papers
Twitter Feed
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.
Sponsored Video
Flash Poll